Makker Gotham 的 Form 4/A 修正申報
修正Rocket Pharmaceuticals, Inc.（RCKT），2024/6/10 申報
- 申報編號
- 0001140361-24-029438
- 申報時間
- 2024/6/10
- 交易日
- 2024/3/21
- 申報延遲
- 81 天
- 10b5-1 計畫
- 沒有勾選
- 原始申報日
- 2024/3/25
這份申報列了 1 筆非衍生性交易。公開市場賣出合計 $779.0 萬。交易後 81 天申報。
這份修正申報取代了 0001140361-24-015103（2024/3/25 申報）。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Makker GothamCIK 0001726391 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2024/3/21 | Common Stock | S賣出處分 | −274,000 | $28.43 | −$7,789,820 | 365,912 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
The securities may be deemed beneficially owned by Gotham Makker, M.D., who serves as the Chief Executive Officer and Chief Investment Officer of Simran Investment Group and who is a director of the Issuer. Dr. Makker exercises voting and dispositive control over the securities held by Simran Investment Group and is therefore deemed be the beneficial owner of securities owned or controlled by Simran Investment Group. Notwithstanding the foregoing, Dr. Makker disclaims personal beneficial ownership of the reported securities held by Simran Investment Group, except to the extent of his pecuniary interest therein.
- F2
This Form 4 corrects an error on the original Form 4 filed on March 25, 2024, which omitted shares of the issuer's common stock held by a non-revocable trust for the benefit of the reporting person's children that should have been included on the original Form 4.
- F3
The securities may be deemed to be beneficially owned by the reporting person and are held by a non-revocable trust for the benefit of the reporting person's children. The reporting person has no voting or investment power over all securities owned by the trust.